Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline + lamotrigine for chronic low back pain
2013-004564-55Phase 2Completed
- Sponsor
- Meditop Pharmaceutical
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic low back pain (CLBP) comparing Sertraline + lamotrigine with Placebo (2 arms). Primary endpoint: Change in pain severity. Started Dec 2013; status: completed.
02
Drugs
sertralinelamotrigine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2013-004564-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004564-55.